Evidence map›Paper›PMID 35794940›Full record

ArticleOpen forum infectious diseases2022

Early Switch From Intravenous to Oral Antibiotics in Skin and Soft Tissue Infections: An Algorithm-Based Prospective Multicenter Pilot Trial.

Sandra Dellsperger, Simea Kramer, Michael Stoller, Annika Burger, Elio Geissbühler, Isabel Amsler, Anna Hirsig, Linda Weyer, Ursula Hebeisen, Philipp Aebi and 11 more

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 1 country.

Sandra DellspergerClinic of Internal Medicine, Emmental Hospital, Langnau, Switzerland.
Simea KramerClinic of Internal Medicine, Emmental Hospital, Burgdorf, Switzerland.
Michael StollerClinic of Internal Medicine, Emmental Hospital, Burgdorf, Switzerland.
Annika BurgerClinic of Internal Medicine, Emmental Hospital, Langnau, Switzerland.
Elio GeissbühlerClinic of Internal Medicine, Emmental Hospital, Langnau, Switzerland.
Isabel AmslerClinic of Internal Medicine, Emmental Hospital, Langnau, Switzerland.
Anna HirsigClinic of Internal Medicine, Emmental Hospital, Langnau, Switzerland.
Linda WeyerClinic of Internal Medicine, Emmental Hospital, Langnau, Switzerland.
Ursula HebeisenClinic of Internal Medicine, Emmental Hospital, Burgdorf, Switzerland.
Philipp AebiClinic of Internal Medicine, Emmental Hospital, Langnau, Switzerland.
Nicolas BurgherrClinic of Internal Medicine, Emmental Hospital, Langnau, Switzerland.
Fabienne BrüggerClinic of Internal Medicine, Emmental Hospital, Burgdorf, Switzerland.
Edouard ChaixDepartment of Internal Medicine, Spitalzentrum Biel, Biel/Bienne, Switzerland.
Jérôme SalamoniDepartment of Internal Medicine, Spitalzentrum Biel, Biel/Bienne, Switzerland.
Sandra GlauserClinic of Internal Medicine, Emmental Hospital, Langnau, Switzerland.
Annina Elisabeth BüchiDepartment of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Charles BéguelinDepartment of Internal Medicine, Spitalzentrum Biel, Biel/Bienne, Switzerland.
Gabriel WaldeggClinic of Internal Medicine, Emmental Hospital, Burgdorf, Switzerland.
Bernhard KesslerClinic of Internal Medicine, Emmental Hospital, Burgdorf, Switzerland.
Martin EggerClinic of Internal Medicine, Emmental Hospital, Langnau, Switzerland.
Parham SendiInstitute for Infectious Diseases, University of Bern, Bern, Switzerland.ORCID https://orcid.org/0000-0002-7347-6312
Regionalspital Emmental · CHSpitalzentrum Centre hospitalier Biel- Bienne · CHUniversity of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In hospitalized patients with skin and soft tissue infections (SSTIs), intravenous (IV) empiric antibiotic treatment is initiated. The best time point for switching from IV to oral treatment is unknown. We used an algorithm-based decision tree for the switch from IV to oral antibiotics within 48 hours and aimed to investigate the treatment outcome of this concept. Methods: In a nonrandomized trial, we prospectively enrolled 128 patients hospitalized with SSTI from July 2019 to May 2021 at 3 institutions. Clinical and biochemical response data during the first week and at follow-up after 30 days were analyzed. Patients fulfilling criteria for the switch from IV to oral antibiotics were assigned to the intervention group. The primary outcome was a composite definition consisting of the proportion of patients with clinical failure or death of any cause. Results: Ninety-seven (75.8%) patients were assigned to the intervention group. All of them showed signs of clinical improvement (ie, absence of fever or reduction of pain) within 48 hours of IV treatment, irrespective of erythema finding or biochemical response. The median total antibiotic treatment duration was 11 (interquartile range [IQR], 9-13) days in the invention group and 15 (IQR, 11-24) days in the nonintervention group ( Conclusions: In this pilot trial, the proposed decision algorithm for early switch from IV to oral antibiotics for SSTI treatment was successful in 95% of cases.

Indexed as

cellulitiserysipelasoral antibioticsskin and soft tissue infection

Identifiers

PMID35794940
PMCPMC9251671
OpenAlexW4223479624

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.